Abstract:Background:: Ischemic stroke, the most common type of cerebrovascular accident, is a major cause of severe disability among adults worldwide. Although there has been progress in interventions for ischemic stroke in the past decades, there is no effective treatment to prevent brain damage in acute ischemic stroke. Therefore, it is urgent to develop novel neuroprotective agents with a wide therapeutic time window to provide a better prognosis for ischemic stroke patients. Objective:: The current study aimed to synthesize novel derivatives with substituent cinnamide scaffolds, evaluate biological activity, and obtain neuroprotective agents. Methods:: The target compounds were synthesized using classical methods of medicinal chemistry. The neuroprotective effects in vitro against Glu-induced neurotoxicity injury were evaluated in PC12 cells by MTT assay. The cell apoptosis was analyzed by flow cytometer. The proteins were detected by western blotting. The neuroprotective activities in vivo were determined in two in vivo models of global and focal cerebral ischemia. Results:: Among the title compounds, 9t, 9u, 9y, and 9z exhibited good neuroprotection in vivo and in vitro, which were selected and further studied to determine their mechanism of action. 9t, 9u, 9y and 9z protected PC12 cells against glutamate-induced apoptosis in a dose-dependent manner via caspase-3 pathway. Moreover, the four compounds significantly reduced brain infarct area and exhibited excellent neuroprotective activities in the in vivo MCAO model. Conclusion:: Compounds 9t, 9u, 9y, and 9z, as potent neuroprotective agents with anti- neurotoxicity activity in vitro and anticerebral infarction efficacy in vivo, might serve as a useful molecular tool for further physiology and pathophysiology function studies, leading to potential clinical therapeutic agents for ischemic injury.

Discovery of 3-N-butyl-2,3-dihydro-1h-isoindol-1-one As A Potential Anti-Ischemic Stroke Agent

Discovery of a potential anti-ischemic stroke agent: 3-pentylbenzo[c]thiophen-1(3H)-one.

Synthesis of Novel 3-Butylphthalide Derivatives Containing Isopentenylphenol Moiety as Potential Antiplatelet Agents for the Treatment of Ischemic Stroke

Novel Hybrids of Optically Active Ring-Opened 3-N-butylphthalide Derivative and Isosorbide As Potential Anti-Ischemic Stroke Agents.

Discovery of novel danshensu derivatives bearing pyrazolone moiety as potential anti-ischemic stroke agents with antioxidant activity

Discovery of a Ring-Opened Derivative of 3-N-butylphthalide Bearing NO/H2S-donating Moieties As a Potential Anti-Ischemic Stroke Agent.

Novel Hybrids of 3-N-butylphthalide and Edaravone: Design, Synthesis and Evaluations As Potential Anti-Ischemic Stroke Agents

Discovery of novel brain-penetrant GluN2B NMDAR antagonists via pharmacophore-merging strategy as anti-stroke therapeutic agents

Design, synthesis, and neuroprotective effects of novel hybrid compounds containing edaravone analogue and 3-<i>n</i>-butylphthalide ring-opened derivatives

Design, Synthesis, and Evaluation of NDGA Analogues As Potential Anti-Ischemic Stroke Agents.

Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke

Discovery of Pyridone-Substituted Triazolopyrimidine Dual A2A/A1 AR Antagonists for the Treatment of Ischemic Stroke.

Design, Synthesis, and Biological Evaluation of Ligustrazine/resveratrol Hybrids As Potential Anti-Ischemic Stroke Agents.

Novel brain-targeting 3-<i>n</i>-butylphthalide prodrugs for ischemic stroke treatment

The Discovery of Novel ACA Derivatives As Specific TRPM2 Inhibitors That Reduce Ischemic Injury Both in Vitro and in Vivo.

Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment

Design and Synthesis of the Ring-Opened Derivative of 3-N-butylphthalide-ferulic Acid-Glucose Trihybrids As Potential Anti-Ischemic Agents

Design, Synthesis, and Biological Evaluation of Novel Cinnamide Derivatives as Neuroprotective Agents for the Treatment of Cerebral Ischemia

Design, Synthesis, and Evaluation of the Novel Ozagrel-Paeonol Codrug with Antiplatelet Aggregation Activities As a Potent Anti-Stroke Therapeutic Agent

Synthesis and Evaluation of 3‐(furo[2,3‐b]pyridin‐3‐yl)‐4‐(1h‐indol‐3‐yl)‐maleimides As Novel GSK‐3β Inhibitors and Anti‐Ischemic Agents

Novel Hybrids of 6-Amino-3-n-butylphthalide and Neuroprotective Groups against Ischemic Stroke